Pharma Deals Review, Vol 2002, No 26 (2002)

Font Size:  Small  Medium  Large

Women First HealthCare Acquire Vaniqa from BMS

Business Review Editor

Abstract


Women First HealthCare acquired exclusive worldwide rights to Vaniqa (eflornithine hydrochloride) Cream from Bristol-Myers Squibb and Gillette. Women First could pay US$38.5 M to acquire the product rights.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.